240 related articles for article (PubMed ID: 27430246)
1. A single nucleotide polymorphism in the 3'-untranslated region of the KRAS gene disrupts the interaction with let-7a and enhances the metastatic potential of osteosarcoma cells.
Zhang S; Hou C; Li G; Zhong Y; Zhang J; Guo X; Li B; Bi Z; Shao M
Int J Mol Med; 2016 Sep; 38(3):919-26. PubMed ID: 27430246
[TBL] [Abstract][Full Text] [Related]
2. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.
Hu H; Zhang L; Teng G; Wu Y; Chen Y
Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738
[TBL] [Abstract][Full Text] [Related]
3. A Single Nucleotide Polymorphism (rs1056629) in 3'-UTR of MMP-9 is Responsible for a Decreased Risk of Metastatic Osteosarcoma by Compromising its Interaction with microRNA-491-5p.
Tian X; Zhang X
Cell Physiol Biochem; 2016; 38(4):1415-24. PubMed ID: 27023472
[TBL] [Abstract][Full Text] [Related]
4. miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.
Niu J; Sun Y; Guo Q; Niu D; Liu B
Dis Markers; 2016; 2016():7068986. PubMed ID: 27777493
[TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
[TBL] [Abstract][Full Text] [Related]
6. Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levels.
Crowley EH; Arena S; Lamba S; Di Nicolantonio F; Bardelli A
Hum Mutat; 2014 Feb; 35(2):208-14. PubMed ID: 24282149
[TBL] [Abstract][Full Text] [Related]
7. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.
Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H
J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438
[TBL] [Abstract][Full Text] [Related]
8. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
9. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
10. miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression.
Gao Y; Luo LH; Li S; Yang C
Biochem Biophys Res Commun; 2014 Feb; 444(2):230-4. PubMed ID: 24462867
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4.
Xiao Y; Zhao Q; Du B; Chen HY; Zhou DZ
Cancer Invest; 2018 Jan; 36(1):1-9. PubMed ID: 29303365
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
[TBL] [Abstract][Full Text] [Related]
13. CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
Han Q; Li C; Cao Y; Bao J; Li K; Song R; Chen X; Li J; Wu X
Cancer Med; 2019 Jul; 8(8):3981-3991. PubMed ID: 31150156
[TBL] [Abstract][Full Text] [Related]
14. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages-derived exo-let-7a promotes osteosarcoma metastasis via targeting C15orf41 in osteosarcoma.
Yan CF; Xia J; Qun WS; Bing WY; Guo WJ; Yong HG; Chen-Jie ; Sheng SJ; Lei ZG; Huang-Xin
Environ Toxicol; 2023 Jun; 38(6):1318-1331. PubMed ID: 36919336
[TBL] [Abstract][Full Text] [Related]
16. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
Wang M; Hu Y; Amatangelo MD; Stearns ME
Mol Cancer Res; 2011 Jan; 9(1):36-50. PubMed ID: 21148031
[TBL] [Abstract][Full Text] [Related]
17. A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.
Kazmi HR; Chandra A; Kumar S; Satyam LK; Gupta A; Nigam J; Srivastava M; Mittal B
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2577-2583. PubMed ID: 27620744
[TBL] [Abstract][Full Text] [Related]
18. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
Xu Z; Wang T
Biochem Biophys Res Commun; 2014 Jun; 449(2):190-5. PubMed ID: 24802407
[TBL] [Abstract][Full Text] [Related]
19. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.
Guo M; Zhao X; Yuan X; Jiang J; Li P
Oncotarget; 2017 Apr; 8(17):28226-28236. PubMed ID: 28415668
[TBL] [Abstract][Full Text] [Related]
20. A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy.
Zhou J; Peng R; Li T; Luo X; Peng H; Zha H; Yin P; Wen L; Zhang Z
Gene; 2013 Sep; 527(2):456-61. PubMed ID: 23860321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]